Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect
Michele D’Alto(Ospedale Monaldi), Raffaele Calabrò(University of Campania "Luigi Vanvitelli"), Giuseppe Santoro(Ospedale D. Cotugno), Fabio Ferrante(Sapienza University of Rome), Massimo Mancone(Sapienza University of Rome), Berardo Sarubbi(Parthenope University of Naples), Roberto Poscia(Policlinico Umberto I), Carmine Dario Vizza(Policlinico Umberto I), Maria Giovanna Russo(University of Campania "Luigi Vanvitelli"), Emanuele Romeo(University of Campania "Luigi Vanvitelli"), Paola Argiento(University of Campania "Luigi Vanvitelli"), F Fedele(Sapienza University of Rome), Roberto Badagliacca(Policlinico Umberto I)
Cited by 82
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults and Special Considerations in Pulmonary Hypertension: Recommendations from the American Society of Echocardiography
|Journal of the American Society of Echocardiography|2025|264
Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension
|International Journal of Cardiology|2013|242
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
|The Journal of Heart and Lung Transplantation|2020|207